Related Experiment Video
Updated: Sep 30, 2025

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
Published on: October 25, 2024
Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of
James R Michels1, Mohammad Shaheed Nazrul2, Sudeep Adhikari3
1Biomedical Engineering, University of Mississippi, University, MS, USA. apavel@olemiss.edu.
Insights
Severe inflammation in COVID-19 patients links to heart issues. Helper T-cell pathways (Th1, Th2, Th17) predict cardiometabolic proteins, offering insights into disease complications and potential treatments.
Area of Science:
- Immunology
- Cardiology
- Virology
Background:
- Severe systemic inflammation is a primary complication in SARS-CoV-2 (COVID-19) patients, frequently leading to tissue damage, organ failure, and cardiovascular comorbidities.
- Understanding the interplay between immune responses and cardiovascular health is crucial for improving medical decisions and therapeutic strategies in COVID-19 management.
Purpose of the Study:
- To investigate the synergistic correlation between helper T-cell inflammatory pathways (Th1, Th2, and Th17) and cardiometabolic proteins in the serum of COVID-19 patients.
- To determine if specific immune signaling molecules can predict the expression levels of cardiometabolic proteins.
Main Methods:
- Serum samples from COVID-19 patients were analyzed.
- Cytokine and chemokine levels associated with Th1, Th2, and Th17 pathways were measured.
- Olink proteomics was employed to profile the expression of 186 cardiometabolic proteins.
Main Results:
- A significant correlation was observed between Th1, Th2, and Th17 pathway cytokines and chemokines and the expression of 186 cardiometabolic proteins.
- These inflammatory markers demonstrated predictive capability for the expression levels of numerous cardiometabolic proteins.
Conclusions:
- Helper T-cell mediated inflammatory pathways are strongly associated with cardiometabolic protein expression in COVID-19.
- The findings suggest that immune dysregulation in COVID-19 directly impacts cardiovascular-related protein profiles, potentially identifying new therapeutic targets.
Abstract:
A predominant source of complication in SARS-CoV-2 patients arises from a severe systemic inflammation that can lead to tissue damage and organ failure. The high inflammatory burden of this viral infection often results in cardiovascular comorbidities. A better understanding of the interaction between immune pathways and cardiovascular proteins might inform medical decisions and therapeutic approaches. In this study we hypothesized that helper T-cell inflammatory pathways (Th1, Th2 and Th17) synergistically correlate with cardiometabolic proteins in serum of COVID-19 patients. We found that Th1, Th2 and Th17 cytokines and chemokines are able to predict expression of 186 cardiometabolic proteins profiled by Olink proteomics.
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response I: Vascular and Cellular

